Company Outlook & Vision
|
Medipattern® was founded with the focus to look for patterns in medical imaging that may show signs of early disease. Medipattern’s co-founder, president and CEO, Jeff Collins, discusses Medipattern’s vision in an interview with Dale Jackson. “We are now launching a new product in vascular imaging. Our new product enables physicians to look at patients at-risk [to stroke] in the convenience of their own offices. The new product is Visualize:Vascular [which] helps healthcare practitioners render the blood flowing through the carotid artery to the brain in 3D and we received FDA clearance earlier this year. We are well on our way to reach 10,000 scans per month.”
|
Forward-looking statements
These interviews contain forward-looking statements relating to Medipattern's performance, operations, or business environment. These statements are based on what we believe are reasonable assumptions given currently available information and our understanding of Medipattern's current activities. We have tried, whenever possible, to identify these forward-looking statements using words such as "anticipates,'' "believes,'' "estimates,'' "expects,'' "plans,'' "intends,'' "potential'', and similar expressions. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict or control. A number of factors could cause actual outcomes and results to differ materially from those expressed in forward-looking statements. These factors include but are not limited to those set forth in the Company's corporate filings, (posted at www.sedar.com). In addition, these forward-looking statements relate to the date on which they are made. The Company disclaims any intention or obligation to update or revise any forward-looking statements for any reason. Readers should not rely on forward-looking statements.